Homes
Public Notices
News
Local news
Editor’s Pick
Pittsburgh
Local Government
Roads, Travel and Traffic
20 Years of Gas Drilling
Regional
U.S. and World
Business
Sports
HS Sports
College Sports
Penguins
Pirates
Steelers
Athlete of the Week
Wild Things
Pony Baseball
Outdoors
Columns
Opinion
Columns
Editorials
Letters to the Editor
Op Eds
Living
Neighbors
School News
Entertainment
Home and Garden
Food
Police Beat
Obituaries
Classifieds
Legal Notices
Sponsored Content
e-Edition
close
Washington County
Greene County
Mon Valley
News
Local news
Police Beat
Pittsburgh
Local Government
Roads, Travel and Traffic
Helping The Helpers
20 Years of Gas Drilling
Regional
U.S. and World
Business News
Sports
High School Sports
College Sports
Penguins
Pirates
Steelers
Wild Things
Pro Sports
Outdoors
Sports Column
Obituaries
Opinion
Columns
Editorials
Letters to the Editor
Op-Ed
Living
Neighbors
Health and Wellness
Entertainment
Home and Garden
Classifieds
Contact Us
Advertise With Us
Customer Service
Contact Information
Submission Forms
Statement of Values
Misc
Special Sections
Events
Sponsored Content
Newsletter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Latest News about BIIB
Recent news which mentions BIIB
< Previous
1
2
...
26
27
28
29
30
31
32
33
Next >
Biogen Earnings Conference Call Is Coming Up, Here's What You Need To Know
April 21, 2022
Tickers
BIIB
Tags
Earnings
News
Benzinga
From
Benzinga
7 Potential Biotech Stocks Buyout Targets in 2022
April 21, 2022
Tickers
ALNY
AMGN
AZN
BIIB
Tags
LLY
ALNY
VRTX
From
InvestorPlace
Why This Analyst Believes Biogen Is 'Too Good to Ignore'
April 18, 2022
Tickers
BIIB
Tags
Benzinga
Wells Fargo
Analyst Color
From
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For April 18, 2022
April 18, 2022
Tickers
AJG
APTV
AXTA
BCRX
Tags
DAL
REFI
SIRI
From
Benzinga
3 Biotech Stocks That Could Help Make You a Fortune
April 14, 2022
Tickers
AMGN
BIIB
MRNA
NVAX
Tags
MRNA
BIIB
Market News
From
Motley Fool
Biogen’s Aduhelm Crashes the Biotech Sector
April 13, 2022
Tickers
BIIB
NVS
VTRS
Tags
VTRS
BIIB
Market News
From
InvestorPlace
Recession Fears are Creating a Golden Opportunity for Biotech Stocks
April 08, 2022
Tickers
AZN
BIIB
ENTX
GLSI
Tags
LGVN
GME
AZN
From
InvestorPlace
Why Is Trevi Therapeutics (TRVI) Stock On the Move Today?
April 08, 2022
Tickers
BIIB
CRWD
EDU
TRVI
Tags
TRVI
NASDAQ:TRVI,NASDAQ:CRWD,NYSE:EDU,NASDAQ:BIIB
Today's Market
From
InvestorPlace
Why Is Biogen (BIIB) Stock in the Spotlight Today?
April 08, 2022
Tickers
BIIB
LLY
Tags
Today's Market
Market News
NASDAQ:BIIB,NYSE:LLY
From
InvestorPlace
Morning Brief: Top Stories Dominating Financial Media on Friday, April 8
April 08, 2022
Tickers
AMZN
BA
BIIB
BRK-A
Tags
ULCC
PYPL
NIO
From
Benzinga
Layoffs at Bluebird Bio Highlight the Current Struggles of Biotech Picks
April 08, 2022
Tickers
BIIB
BLUE
GILD
IBB
Tags
NVS
MRNA
BIIB
From
InvestorPlace
Biogen's Alzheimer's Drug Aduhelm Medicare Coverage Restricted To Just Clinical Trials, CMS Finalizes
April 08, 2022
Tickers
BIIB
Tags
Biotech
Aduhelm
Health Care
From
Benzinga
3 Healthcare Stocks That Could Help Set You Up for Life
April 07, 2022
Tickers
BIIB
GMED
LLY
SGEN
Tags
LLY
BIIB
SGEN
From
Motley Fool
Could Amylyx Pharmaceuticals Have a Blockbuster ALS Treatment?
March 29, 2022
Tickers
AMLX
BIIB
Tags
AMLX
Recent Press Releases
Market News
From
Motley Fool
Ionis-Biogen Partnered Amyotrophic Lateral Sclerosis Trial Disappoints
March 28, 2022
Tickers
BIIB
IONS
Tags
Phase 1 Trial
Briefs
Trading Ideas
From
Benzinga
Is Johnson & Johnson Setting a Dangerous Precedent for the Healthcare Industry?
March 26, 2022
Tickers
BIIB
JNJ
MRNA
OCGN
Tags
JNJ
OCGN
Market News
From
Motley Fool
Why I Sold Kohl’s Corporation Despite Possible Buyout Deal
March 22, 2022
Tickers
BIIB
KSS
NLSN
Tags
NLSN
NYSE:KSS,NYSE:NLSN,NASDAQ:BIIB
KSS
From
InvestorPlace
Biogen, Eisai Unveil New Data On Another Alzheimer's Candidate, Lecanemab
March 22, 2022
Tickers
BIIB
ESALF
ESALY
Tags
Benzinga
News
Briefs
From
Benzinga
2 Red Flags for Biogen's Future
March 22, 2022
Tickers
BIIB
LLY
Tags
Recent Press Releases
BIIB
LLY
From
Motley Fool
Biogen Shares Aduhelm Data In Alzheimer's Disease At 128 Weeks
March 16, 2022
Tickers
BIIB
Tags
News
General
Benzinga
From
Benzinga
Biogen, Eisai Amend Their Alzheimer's Drug Marketing Pact
March 15, 2022
Tickers
BIIB
ESALF
ESALY
Tags
Alzheimer's disease
General
Health Care
From
Benzinga
The Daily Biotech Pulse: Biogen, Eisai Amend Aduhelm Agreement; Anaptys Acne Drug Flunks Midstage Study; Merck, AstraZeneca Discontinue Prostate Cancer Trial
March 15, 2022
Tickers
ALT
ANAB
ANIP
ATHX
Tags
ANIP
EXEL
ATHX
From
Benzinga
Biogen Posts New Updates Across its Spinraza SMA Research Program
March 14, 2022
Tickers
BIIB
NVS
RHHBY
Tags
Biotech
NVS
RHHBY
From
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For March 8, 2022
March 08, 2022
Tickers
ACET
ACTD
ALEC
AREN
Tags
Market News
SPRB
COP
From
Benzinga
10 Biggest Price Target Changes For Tuesday
March 08, 2022
Tickers
AUPH
AVDX
BBBY
BIIB
Tags
BBBY
DTM
Price Target
From
Benzinga
As President Biden proposed, Medicare needs the ability to negotiate drug prices
March 07, 2022
Tickers
BIIB
Tags
BIIB
From
MarketWatch
The Daily Biotech Pulse: Ocugen Faces Regulatory Setback, vTv CEO Quits, Biogen-Eisai Make Headway With Second Alzheimer's Antibody Treatment In Japan
March 04, 2022
Tickers
BIIB
CEMI
ESALY
EYEN
Tags
General
FDA
Offerings
From
Benzinga
Why This Analyst Sees Roughly 20% Upside In This Large-Cap Biopharma
March 03, 2022
Tickers
BIIB
Tags
Brian Abrahams
RBC Capital Markets
Biotech
From
Benzinga
Expert Ratings For Biogen
March 03, 2022
Tickers
BIIB
Tags
BIIB
Analyst Ratings
Market News
From
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For March 3, 2022
March 03, 2022
Tickers
ALGT
AORT
AVTX
BALY
Tags
BZI/Ratings
CCSI
SCPL
From
Benzinga
< Previous
1
2
...
26
27
28
29
30
31
32
33
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
Starting at $3.75
/
week.
Subscribe Today